tradingkey.logo

Park Ha Biological Technology Co Ltd

PHH

14.260USD

-0.580-3.91%
Close 05/02, 16:00ETQuotes delayed by 15 min
356.50MMarket Cap
--P/E TTM

Park Ha Biological Technology Co Ltd

14.260

-0.580-3.91%
More Details of Park Ha Biological Technology Co Ltd Company
Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The Company mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The Company's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The Company mainly conducts its business in domestic market.
Company Info
Company codePHH
Company namePark Ha Biological Technology Co Ltd
IPO dateDec 27, 2024
Founded at2022
CEOMs. Xiaoqiu Zhang
Number of employees31
Security typeOrdinary Share
Fiscal year-endDec 27
Address14F, Building 3
CityWUXI
Stock exchangeNASDAQ Capital Market Consolidated
CountryChina
Postal code214135
Phone864000127562
Websitehttp://ir.parkha.cn/
Company codePHH
IPO dateDec 27, 2024
Founded at2022
Company Executives
Name
Name/Position
Position
Shareholding
Change
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Mr. Xiaozhong Yu
Mr. Xiaozhong Yu
Independent Director Nominee
Independent Director Nominee
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Revenue Breakdown
FY2024
FY2023
FY2022
FY2021
No Data
By RegionCNY
Name
Revenue
Proportion
China (Mainland)
2.38M
0.00%
By Business
By Region
No Data
Shareholder
Update time: 19 hours ago
Update time: 19 hours ago
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Xiaoqiu Holding Ltd
72.23%
Changxin International Ltd Partnership
9.48%
Citadel Advisors LLC
0.11%
Jane Street Capital, L.L.C.
0.10%
HRT Financial LP
0.08%
Other
18.00%
Shareholder Statistics
Shareholder
Proportion
Xiaoqiu Holding Ltd
72.23%
Changxin International Ltd Partnership
9.48%
Citadel Advisors LLC
0.11%
Jane Street Capital, L.L.C.
0.10%
HRT Financial LP
0.08%
Other
18.00%
Type
Shareholder
Proportion
Corporation
81.71%
Hedge Fund
0.11%
Research Firm
0.10%
Investment Advisor
0.09%
Other
17.99%
Institutional Shareholding
Update time: Tue, Mar 4
Update time: Tue, Mar 4
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
6
21.63M
82.01%
+79.91K
2024Q4
6
21.63M
82.55%
+21.63M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Xiaoqiu Holding Ltd
19.05M
72.23%
--
--
Feb 24, 2025
Changxin International Ltd Partnership
2.50M
9.48%
--
--
Feb 24, 2025
Citadel Advisors LLC
29.74K
0.11%
+29.74K
--
Dec 31, 2024
Jane Street Capital, L.L.C.
25.66K
0.1%
+25.66K
--
Dec 31, 2024
HRT Financial LP
21.43K
0.08%
+21.43K
--
Dec 31, 2024
UBS Financial Services, Inc.
3.08K
0.01%
+3.08K
--
Dec 31, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data